Security key
88025U109
10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG)
CUSIP: 88025U109
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Class A Common Stock, $0.00001 par value per share
- Total 13F shares
- 128,495,444
- Total 13F value
- $4,920,669,893
- Share change
- +3,533,608
- Put/Call ratio
- 17%
- SEC-reported price per share
- $38.34
- Number of holders
- 389
- Value change
- +$188,006,280
- Number of buys
- 196
- Number of sells
- 173
- Shares outstanding
- 116,858,154
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
389
Top holders
10
TXG full security history
Ownership snapshot
Full 13F holder table
10x Genomics, Inc. SEC filings
10x Genomics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
ARK Investment Management...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 16%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 16%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
16%
VANGUARD GROUP INC
12%
ARK Investment Management LLC
8.6%
BlackRock, Inc.
7.6%
Sumitomo Mitsui Trust Group, Inc.
4.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
Company
|
16%
from 13D/G
|
$376,640,828
17,740,972 shares
|
— | 31 Mar 2026 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
12%
|
$155,176,941
13,274,332 shares
|
$0 | 30 Sep 2025 |
| ARK Investment Management LLC |
13D/G
13F
Company
|
8.6%
|
$383,517,244
10,003,058 shares
|
-$72,245,519 | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.6%
from 13D/G
|
$213,996,552
10,079,913 shares
|
— | 31 Mar 2026 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
13D/G
Company
|
4.7%
from 13D/G
|
$108,489,843
5,110,214 shares
|
— | 31 Mar 2026 |
| Amova Asset Management Americas, Inc. |
13F
13D/G
Company
|
4.7%
from 13D/G
|
$108,310,657
5,104,178 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
389
Shares
128,495,444
Rows available
389
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
329
Q2 2026 holders
389
Holder diff
60
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|